4.6 Article

pDC depletion induced by CD317 blockade drives the antitumor immune response in head and neck squamous cell carcinoma

Journal

ORAL ONCOLOGY
Volume 96, Issue -, Pages 131-139

Publisher

ELSEVIER
DOI: 10.1016/j.oraloncology.2019.07.019

Keywords

Head and neck cancer; Plasmacytoid dendritic cells; Immunosuppressive cells; Immune checkpoints; Transgenic mouse model; Tissue microarray

Funding

  1. National Natural Science Foundation of China [81874131, 81672668, 81672667]
  2. Hubei Province Natural Science Funds for Distinguished Young Scholar [2017CFA062]

Ask authors/readers for more resources

Objectives: Dysregulation of immune cells in the tumor microenvironment is a hallmark of head and neck squamous cell carcinoma (HNSCC). Increased infiltration of pDCs has been reported in the microenvironment of HNSCC. However, the precise immunological role of pDC and the therapeutic effects of pDC depletion in HNSCC need to be further investigated. Materials and methods: CD317 antibodies were applied for depleting pDCs in an immunocompetent transgenic HNSCC mouse model. Tumor volume was monitored. Flow cytometric analysis was conducted for studying the immune profile changes after pDC depletion. In addition, immunohistochemical staining was carried out in a human HNSCC tissue microarray for detecting the infiltration of pDCs. We also analyzed the survival implication of pDCs and its correlation with other immune related markers in human HNSCC. Results: pDC depletion in the transgenic HNSCC mouse model significantly delayed tumor growth. After pDCs were depleted, T cells were markedly revitalized, and the proportions of regulatory T cells (Tregs) and monocytic myeloid-derived suppressor cells (MDSCs) were decreased. In human HNSCC microenvironment, pDC infiltration was upregulated and its high infiltration conferred a poor prognosis. Moreover, pDC infiltration was closely correlated with the expression of Foxp-3, PD-1, TIM-3, and LAG-3. Conclusion: Our findings demonstrated that pDCs play a negative immunomodulatory role in HNSCC and may present as a target for effective immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Physical

Implantable versatile oxidized bacterial cellulose membrane for postoperative HNSCC treatment via photothermal-boosted immunotherapy

Jun-Jie Zhou, Xiao-Hong Li, Peng-Yu He, Fu-Yu Qi, Muhammad Wajid Ullah, Shu-Jin Li, Yuan-Tong Liu, Lin-Lin Bu, Guang Yang, Zhi-Jun Sun

Summary: A newly developed multifunctional nanocomposite combining photothermal therapy and immune checkpoint blockade shows potential for controlling local recurrence of HNSCC.

NANO RESEARCH (2023)

Article Chemistry, Multidisciplinary

A Dual-Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis

Wen Su, Wei Qiu, Shu-Jin Li, Shuo Wang, Jun Xie, Qi-Chao Yang, Jiming Xu, Junjie Zhang, Zhigang Xu, Zhi-Jun Sun

Summary: This study reports a combinational therapeutic strategy that combines tumor microenvironment-reactive oxygen species/pH dual-responsive signal transducers and activators of transcription 3 inhibitor nanoprodrugs with oncolytic herpes simplex virus 1 virotherapy to enhance immunotherapy. This strategy successfully activates robust T-cell-dependent antitumor responses, potentiating immune checkpoint blockade effects against local recurrence and pulmonary metastasis in preclinical cold murine triple-negative breast cancer and syngeneic oral cancer models.

ADVANCED MATERIALS (2023)

Article Chemistry, Multidisciplinary

Endogenous/exogenous stimulies inspired polyprodrug nano-inducer switches pyroptosis path for promoting antitumor immunity

Xianbin Ma, Wen Su, Mengjie Ye, Yuan Gao, Wei Qiu, Mengyun Liang, Peng Xue, Yuejun Kang, Zhi-Jun Sun, Zhigang Xu

Summary: In this study, an endogenous/exogenous stimulus-activatable unimolecular polyprodrug, named CCNP, is reported to precisely regulate gasdermin E (GSDME)-mediated tumor pyroptosis. The nano-inducer is specifically triggered by noninvasive laser radiation and tumor microenvironment reactive oxygen species (ROS) and glutathione (GSH), leading to the activation of caspase-3 and the initiation of pyroptosis. This multi-stimulus-responsive nanomedicine provides a new perspective on how to induce and regulate tumor cell pyroptosis for immune checkpoint blockade therapy.

NANO TODAY (2023)

Article Multidisciplinary Sciences

Near-infrared-IIb emitting single-atom catalyst for imaging-guided therapy of blood-brain barrier breakdown after traumatic brain injury

Biao Huang, Tao Tang, Shi-Hui Chen, Hao Li, Zhi-Jun Sun, Zhi-Lin Zhang, Mingxi Zhang, Ran Cui

Summary: The authors designed a near-infrared-IIb emitting Mn single-atom catalyst for imaging-guided therapy to alleviate ROS-mediated neuroinflammation and obtain feedback of therapeutic effect in mice with traumatic brain injury. The catalyst promoted the reconstruction of blood-brain barrier and recovery of neurological function.

NATURE COMMUNICATIONS (2023)

Article Engineering, Biomedical

Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy

Shu-Cheng Wan, Meng-Jie Ye, Qi-Chao Yang, Tian Zhang, Meng-Jie Zhang, Xian-Bin Ma, Ji-Ming Xu, Shuo Wang, Zhi-Zhong Wu, Lei-Lei Yang, Xue-Meng Shen, Zhigang Xu, Zhi-Jun Sun

Summary: Pyroptosis triggers antitumor immunity and this study introduces a dual-responsive diselenide-based pyroptosis inducer that has excellent tumor microenvironment targeting effects. It can remodel the immunostimulated tumor microenvironment and trigger a robust immune response. Combined with αPD-1 therapy, it effectively inhibits the growth of remote tumors and prolongs survival.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Oncology

Immunogenic hypofractionated radiotherapy sensitising head and neck squamous cell carcinoma to anti-PD-L1 therapy in MDSC-dependent manner

Liang Mao, Jun-Jie Zhou, Yao Xiao, Qi-Chao Yang, Shao-Chen Yang, Shuo Wang, Zhi-Zhong Wu, Hong-Gang Xiong, Hai-Jun Yu, Zhi-Jun Sun

Summary: Combining immunogenic radiotherapy with anti-PD-L1 treatment can enhance the immune response in immunotherapy-resistant HNSCC mouse models.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma

Boxin Zhang, Hao Li, Yuan-Tong Liu, Dian Xiong, Lu Zhang, Zhi-Jun Sun

Summary: This study investigated the spatial architecture of immune cells in tertiary lymphoid structures (TLSs) associated with head and neck squamous cell carcinoma (HNSC). It identified chemokine receptors associated with TLSs and portrayed the cellular atlas using multiplex immunohistochemistry. The study also explored the functions and evolutionary trajectory of cells in TLSs, and proposed a method to enhance the antitumor immune response by inducing neogenesis TLSs in HNSC.

CANCER LETTERS (2023)

Article Oncology

Tumor-host colluding through erythroid progenitor cells: Mechanisms and opportunities

Yuan -Yuan Wang, Zhi-Zhong Wu, Cong-Fa Huang, Zhi-Jun Sun

Summary: Immunotherapy, particularly immune checkpoint blockade (ICB), has shown promise in cancer treatment but its efficacy is limited. This study focuses on understanding the alterations in the systemic immune system and immune macroenvironment and explores the role of the spleen, especially erythroid progenitor cells (EPCs), in tumor progression and immunotherapy. The findings suggest the potential for further research on EPCs and their mechanisms in tumor treatment.

CANCER LETTERS (2023)

Article Immunology

Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC

Jie Liu, Wen -Ping Lin, Wen Su, Zhi-Zhong Wu, Qi-Chao Yang, Shuo Wang, Ting-Guan Sun, Cong-Fa Huang, Xiao-Long Wang, Zhi-Jun Sun

Summary: Combining EZH2 inhibitor and MDSC inhibitor can improve the response rate to immune-checkpoint-blocking therapy and reverse HNSCC-specific immunotherapeutic resistance, making it a promising strategy for overcoming resistance to ICB therapy.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Article Dentistry, Oral Surgery & Medicine

Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV- HNSCC

H. Li, S. -W. Zhu, J. -J. Zhou, D. -R Chen, J. Liu, Z. -Z Wu, W. -Y Wang, M. -J Zhang, Z. -J Sun

Summary: Immune checkpoint blockade therapy targeting PD-1/PD-L1 shows limited efficacy in head and neck squamous cell carcinoma (HNSCC), however, recent findings suggest that the presence of tertiary lymphoid structures (TLSs) in tumor tissue is associated with better prognosis and response to therapy. This study analyzed TCGA-HNSCC data and identified an immune classification for the tumor microenvironment (TME) of HNSCC and found that TLS enrichment was correlated with improved prognosis and response to immune checkpoint blockade treatment. Further experiments demonstrated that inducing TLS formation enhanced the response to PD-1 blockade treatment in HPV- HNSCC mouse models by increasing the presence of specific immune cells in the TME. The results suggest that inducing TLS formation could be a potential therapeutic approach for improving the response rate to immune checkpoint blockade therapy in HPV- HNSCC patients.

JOURNAL OF DENTAL RESEARCH (2023)

Article Oncology

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity

Jun Xie, Shaowei Wang, Yunhong Zhong, Ming Gao, Xuezhang Tian, Liting Zhang, Dongli Pan, Qingsong Qin, Bing Wu, Ke Lan, Zhi-Jun Sun, Junjie Zhang

Summary: Oncolytic viruses encoding various transgenes have been used to reverse the immunosuppressive tumor microenvironment, but the antiviral restriction factors that limit viral replication have been overlooked. In this study, researchers found that expressing a bacterial E3 ubiquitin ligase can effectively counteract a restriction factor and improve viral replication and therapeutic efficacy.

MOLECULAR THERAPY-ONCOLYTICS (2023)

Article Multidisciplinary Sciences

Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer

Qi-Chao Yang, Shuo Wang, Yuan-Tong Liu, An Song, Zhi-Zhong Wu, Shu-Cheng Wan, Hui-Min Li, Zhi-Jun Sun

Summary: PCSK9 expression is upregulated in HNSCC tissues and higher expression is associated with poorer prognosis. Inhibition of PCSK9 suppresses cancer cell stemness via LDLR-dependent mechanism. PCSK9 inhibition enhances CD8(+) T cell infiltration, reduces MDSCs, and improves the efficacy of anti-PD-1 ICB therapy in HNSCC.

ISCIENCE (2023)

Article Oncology

Epigenetic regulation of pyroptosis in cancer: Molecular pathogenesis and targeting strategies

Ruo-Nan Zhang, Zhi-Qian Jing, Lu Zhang, Zhi-Jun Sun

Summary: Immune checkpoint blockade therapy has revolutionized cancer treatment by providing durable responses in advanced and metastatic cancers. However, immune suppressive cells and molecules in the tumor microenvironment can hinder the efficacy of immune checkpoint inhibitors. Pyroptosis, a type of programmed cell death, can transform "cold" tumors to "hot" tumors, enhancing the immune response and preventing tumor growth. Recent evidence suggests that epigenetic regulation of pyroptosis could be a promising therapeutic strategy. This review discusses the mechanism of pyroptosis and summarizes the role of three common epigenetic factors in regulating pyroptosis in cancer. Targeting epigenetic regulation of pyroptosis could provide new insights and advances in cancer therapy.

CANCER LETTERS (2023)

Article Otorhinolaryngology

CSRP2 promotes cell stemness in head and neck squamous cell carcinoma

Meng-Jie Zhang, Jie Liu, Shu-Cheng Wan, Jia-Xing Li, Shuo Wang, Nyimi Bushabu Fidele, Cong-Fa Huang, Zhi-Jun Sun

Summary: The study reveals that CSRP2 plays a crucial role in head and neck squamous cell carcinoma (HNSCC), and its overexpression is associated with poor prognosis. CSRP2 is involved in the regulation of cancer stemness and epithelial-to-mesenchymal transition (EMT) in HNSCC. This research provides a potential therapeutic target for the treatment of HNSCC.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2023)

Article Chemistry, Multidisciplinary

Activation of Pyroptosis Using AIEgen-Based sp(2) Carbon-Linked Covalent Organic Frameworks

Liang Zhang, Shu-Cheng Wan, Jianyu Zhang, Meng-Jie Zhang, Qi-Chao Yang, Boxin Zhang, Wu-Yin Wang, Jianwei Sun, Ryan T. K. Kwok, Jacky W. Y. Lam, Hexiang Deng, Zhi-Jun Sun, Ben Zhong Tang

Summary: Covalent organic frameworks (COFs) have shown potential as porous materials for cancer phototherapy due to their unique characteristics. However, the aggregation-caused quenching effect and apoptosis resistance limit their effectiveness. This study demonstrated that linking AIEgens into COF networks was an effective strategy for inducing pyroptosis and enhancing antitumor immunity. The synergized system of AIE COF and αPD-1 effectively eradicated tumors and inhibited recurrence and metastasis in a tumor model.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Oncology

Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice

Vanita Noronha, Aditya Dhanawat, Vijay Maruti Patil, Nandini Menon, Ajay Kumar Singh, Pankaj Chaturvedi, Prathamesh Pai, Devendra Chaukar, Sarbani Ghosh Laskar, Kumar Prabhash

Summary: Neo-adjuvant chemotherapy has shown long term survival benefits in patients with locally advanced oral cavity squamous cell carcinomas.

ORAL ONCOLOGY (2024)

Article Oncology

Development of machine learning models for the prediction of long-term feeding tube dependence after oral and oropharyngeal cancer surgery

Andrea Costantino, Claudio Sampieri, Gian Marco Pace, Bianca Maria Festa, Luca Cerri, Giorgio Gregory Giordano, Michael Dale, Giuseppe Spriano, Giorgio Peretti, Armando De Virgilio

Summary: This study aimed to predict the necessity of enteral nutrition at 28 days after surgery in patients with head and neck cancers. The results showed that the machine learning models had optimistic accuracy in predicting the need for enteral nutrition, but had moderate sensitivity.

ORAL ONCOLOGY (2024)

Article Oncology

Comprehensive clinical, genome and transcriptomic analysis of primary ghost cell odontogenic carcinoma

Lirui Zhang, Qiaoshi Xu, Zhien Feng

Summary: This study presents a comprehensive clinical, genomic, and transcriptomic analysis of primary ghost cell odontogenic carcinoma (GCOC). The results provide the first comprehensive molecular atlas for primary GCOC, including previously identified CTNNB1 mutation and novel alterations in MAP3K, EP300, and the 22q11.21 region. The transcriptome analysis reveals significant involvement of cytokine-cytokine receptor interaction and the PI3K-Akt signaling pathway. More GCOC cases should be compared to validate these findings for accurate clinical guidance.

ORAL ONCOLOGY (2024)

Article Oncology

Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma

Emily Capone, Vittoria Perrotti, Ilaria Cela, Rossano Lattanzio, Lucrezia Togni, Corrado Rubini, Vito Carlo Alberto Caponio, Lorenzo Lo Muzio, Martina Colasante, Francesco Giansanti, Rodolfo Ippoliti, Stefano Iacobelli, Michael J. Wick, Nicole Spardy Burr, Gianluca Sala

Summary: This study explores the potential of galectin-3 binding protein (LGALS3BP) as a novel target for antibody-drug conjugate (ADC) therapy in adenoid cystic carcinoma (ACC). The results show that LGALS3BP is highly expressed in ACC tissues and treatment with anti-LGALS3BP ADC leads to durable tumor growth inhibition in animal models.

ORAL ONCOLOGY (2024)

Article Oncology

Transoral robotic surgery in oropharyngeal squamous cell carcinoma: A comparative study between da Vinci Single-Port and da Vinci Xi systems

Andrea Costantino, Claudio Sampieri, Piero Giuseppe Meliante, Armando De Virgilio, Se-Heon Kim

Summary: This study compares the outcomes of transoral resections using the da Vinci SP and da Vinci Xi systems for oropharyngeal squamous cell carcinoma (OPSCC). The results indicate that the da Vinci SP system has advantages in terms of reduced docking and console times, as well as improved rates of wide negative resection margins. However, there were no significant differences in complication rates or postoperative functional outcomes between the two systems.

ORAL ONCOLOGY (2024)